Our previous work has shown that 1.2 kb of the 5' flanking region of the mo
use GnRH receptor (mGnRH-R) gene is sufficient to direct tissue-specific ex
pression in vitro. In this study, me have used the cell-specific regulatory
sequences of the mGnRH-R gene promoter to target the expression of the sim
ian virus 40 virus T antigen (TAg) to the pituitary gland of transgenic mic
e. A hybrid transgene, GnRH-R/TAg, was prepared using the - 1164/+52 region
of the mGnRH-R gene and + 2533/+5234 sequences encoding the large T antige
n of the simian Virus 40. Two founders developed tumors of apparent pituita
ry origin at 44 (M28, female) and 50 (M25, male) days of age. M28 and M25 m
ice were about 50% underweight, and their gonads were grossly underdevelope
d compared with wild-type litter mates. A third male founder, M29, develope
d a tumor at a later time (109 days). M29 was able to breed successfully an
d stably transmit the GnRH-R/TAg transgene. Mice of the M29 transgene line
developed tumors at 4-5 months of age. Gross examination showed that the tu
mors extend from the sella and infiltrate into the inferior surface of the
brain. In small tumors collected from young transgenic animals, normal pitu
itary cells as well as transition areas of increasing cellular atypia are e
vident. Frankly malignant cells are seen in all tumors. The pituitary tumor
s express the alpha-, FSH beta-, and LH beta-subunits and the GnRH-R messen
ger RNA, all markers of a gonadotrope but not of other anterior pituitary c
ell lineages. In summary, our studies indicate that 1.2 kb of the 5'-flanki
ng region of the mGnRH-R gene can be used to target expression specifically
to the gonadotropes of the pituitary gland in transgenic mice. The GnRH-R
gene promoter-directed expression appears to be cell-specific and results i
n the formation of tumors that are primarily of gonadotropic origin.